← FDA DRUG APPROVALS

FDA ANDA · ANDA074784

ATRACURIUM BESYLATE

Sponsor: TEVA PARENTERAL

APPLICATION
ANDA074784
TYPE
ANDA
ORIGINAL APPROVAL
1997-06-11
LATEST ACTION
2002-02-26
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ATRACURIUM BESYLATEDiscontinued
ATRACURIUM BESYLATE 10MG/ML · INJECTABLE · INJECTION

Approval history

2002-02-26Labeling · Supplement 1AP
1997-06-11OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →